Bronchostop

Pharmacological properties

Bronchostop is a traditional herbal medicine that is used as an expectorant for cough associated with the common cold, mainly with prolonged therapy. thyme herb essential oils and flavonoids have a bronchodilator, secretolytic, antiseptic and antibacterial effect, thus contributing to the rapid dissolution of sputum accumulated in the respiratory tract, reduce cough, facilitate breathing, and also affect the pathogen.

The composition of the marshmallow root in the syrup includes mucous substances related to polysaccharides, which have a softening, anti-inflammatory and enveloping effect and are used as a treatment for inflammatory diseases of the respiratory tract. Marshmallow root polysaccharides eliminate mucosal irritation and reduce the activity of peripheral cough receptors.

A special formulation of the excipient, a natural base (gum from African acacia), which is found in syrup and lozenges, contributes to the slow release of the active substance, which causes a gradual cessation of secretion of the secretion by the mucous membrane, which reduces irritation of the mucous membrane, activates the saliva and thus the mucous membrane moisturizes, thereby further facilitating the irritation of coughing and coughing stops. Quickly and for a long time protects the mucous membrane receptors of the respiratory tract from irritation.

Thyme herb flavonoids (apigenin, luteolin) are split by intestinal microflora and are well absorbed. Excreted mainly in the urine unchanged or in the form of metabolites.

Indications

Symptomatic treatment of inflammatory diseases of the respiratory tract, accompanied by coughing and the release of thick sputum, which makes it difficult to expectorate, relieve dry cough and reduce irritation of the mucous membrane of the mouth and pharynx.

Application

Bronchostop lozenges. for oral use (apply until complete resorption in the oral cavity). adults and children over the age of 12, 1-2 lozenges every 3-4 hours (4-6 times a day). children aged 6-12 years - 1 lozenge 3 times a day.

If symptoms worsen or the expected effect is not achieved within 5 days, you should immediately consult a doctor.

Bronchostop syrup. Children aged 2 to 4 years after consultation with a doctor are prescribed 7.5 ml every 3-4 hours (4-6 times a day, the maximum daily dose is 45 ml); children aged 4 to 12 years - 7.5 ml every 3-4 hours (4-6 times a day, the maximum daily dose is 45 ml); children over the age of 12 years and adults - 15 ml every 3-4 hours (4-6 times a day, the maximum daily dose is 90 ml).

The measuring cup in the box provides convenient use and more accurate dosing in accordance with the recommended dose.

If symptoms worsen or the expected effect is not achieved within 5 days, consult a doctor.

Bronchostop syrup can be used after dilution in water or in warm tea.

Contraindications

Hypersensitivity to any component of the drug, as well as to other representatives of the lamiaceaea family, as well as sensitivity to celery or pollen of birch (a cross reaction is possible); bah.

For a syrup preparation also: children with a history of acute stenosing laryngotracheitis; BA.

Side effects

For preparations containing thyme, hypersensitivity reactions were noted, including cases of anaphylactic shock and angioedema, and nausea.

If any adverse reactions occur, consult a doctor.

For the preparation in the form of a syrup: delayed-type allergic reactions, increased salivation, irritation of the gastric mucosa are possible; gastrointestinal upsets (including spasm, nausea, diarrhea).

special instructions

If during treatment the symptoms worsen and / or shortness of breath appears, fever, purulent sputum, it is necessary to consult a doctor. if within 1 week the symptoms persist, it is necessary to consult a doctor.

Bronchostop lozenges. Due to the risk of accidentally swallowing a whole lozenge, do not use in children under the age of 6 years. It contains fructose and sorbitol, so if the patient is intolerant of certain sugars, you should consult your doctor before taking this medication. 1 lozenge corresponds to approximately 0.1 carbohydrate units. This should be considered in patients with diabetes.

Bronchostop syrup contains methylparaben (E218) and propylparaben (E216), which can cause allergic reactions (possibly of a delayed type).

Use during pregnancy and lactation. Safety during use during pregnancy and lactation has not been established. It is not recommended to use the drug during pregnancy and lactation.

The ability to influence the reaction rate when driving vehicles or working with other mechanisms. Not installed.

Children. The drug in the form of lozenges is used in children over the age of 6 years. The drug in the form of a syrup is used in children over the age of 1 year.

Interactions

No studies have been conducted.

The absorption of concomitant drugs may decrease. Other drugs must be used 1 hour before or 1 hour after the use of the drug (due to the content of the marshmallow root extract). It is not recommended to be used concurrently with antitussive agents (e.g. codeine).

Overdose

There is no evidence of overdose. in case of accidental overdose, consult a doctor. symptomatic treatment.

Storage conditions

At a temperature not exceeding 25 ° c in a dark place. after using the drug in the form of a syrup, it is recommended to close the bottle tightly.